Cargando…
Predicting In Vivo Efficacy of Potential Restenosis Therapies by Cell Culture Studies: Species-Dependent Susceptibility of Vascular Smooth Muscle Cells
Although drug-eluting stents (DES) are successfully utilized for restenosis therapy, the development of local and systemic therapeutic means including nanoparticles (NP) continues. Lack of correlation between in vitro and in vivo studies is one of the major drawbacks in developing new drug delivery...
Autores principales: | Hila, Epstein, Rabinovich, Laura, Banai, Shmuel, Elazar, Vicktoria, Gao, Jianchuan, Chorny, Michael, Danenebrg, Haim D, Golomb, Gershon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570571/ https://www.ncbi.nlm.nih.gov/pubmed/18949101 http://dx.doi.org/10.2174/1874192400802010060 |
Ejemplares similares
-
Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
por: Smith, Sarah A., et al.
Publicado: (2019) -
Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis
por: Mori, Yusaku, et al.
Publicado: (2021) -
Noncoding RNAs in Vascular Cell Biology and Restenosis
por: Efovi, Denis, et al.
Publicado: (2022) -
Hif-1α/Slit2 Mediates Vascular Smooth Muscle Cell Phenotypic Changes in Restenosis of Bypass Grafts
por: Li, Sen, et al.
Publicado: (2023) -
Lin28a up‐regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells
por: Zou, Zhiwei, et al.
Publicado: (2020)